Revvity Cash Flow Statement
NYSE: RVTYIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Revvity free cash flow
In fiscal 2025, Revvity generated $582.9 million of operating cash flow and spent $73.5 million on capital expenditures. That left free cash flow of $509.4 million, a free-cash-flow margin of 17.8% of revenue. Free cash flow was down 6.0% from the prior year's $541.7 million.
Revvity returned $853.6 million to shareholders: $32.8 million in dividends and $820.8 million in share repurchases, equal to 168% of free cash flow. Free cash flow covered dividend payments 15.5 times.
Summary generated from market data by MetaCap's automated system. Methodology
Revvity cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-28 | FY 20242024-12-29 | FY 20232023-12-31 | FY 20222023-01-01 | FY 20212022-01-02 | FY 20202021-01-03 | FY 20192019-12-29 | FY 20182018-12-30 | FY 20172017-12-31 | FY 20162017-01-01 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 241.20M | 270.38M | 693.09M | 569.18M | 943.16M | 727.89M | 227.56M | 237.93M | 292.63M | 234.30M |
| Net Income growth (YoY) | -10.79% | -60.99% | +21.77% | -39.65% | +29.57% | +219.87% | -4.36% | -18.69% | +24.90% | +10.30% |
| Depreciation & Amortization | 405.34M | 427.85M | 431.77M | 427.00M | 311.44M | 201.65M | 214.03M | 180.59M | 105.00M | 99.97M |
| Stock-Based Compensation | 22.85M | 37.81M | 41.41M | 51.52M | 29.68M | 26.90M | 31.51M | 28.77M | 25.42M | 17.16M |
| Change in Working Capital | -78.90M | 3.09M | -99.53M | -26.34M | -142.49M | 824.94M | 137.99M | -115.80M | -20.23M | 18.51M |
| Operating Cash Flow | 582.93M | 628.30M | 91.27M | 679.81M | 1.41B | 892.18M | 363.47M | 311.04M | 288.45M | 350.62M |
| Capital Expenditures | -73.52M | -86.65M | -81.37M | -85.63M | -86.02M | -63.63M | -76.33M | -93.25M | -39.09M | -31.70M |
| Investing Cash Flow | -17.35M | 776.16M | 1.31B | -132.85M | -4.11B | -504.50M | -487.57M | -159.86M | -1.27B | -83.88M |
| Dividends Paid | -32.80M | -34.45M | -34.97M | -35.34M | -32.37M | -31.21M | -31.06M | -31.01M | -30.79M | -30.80M |
| Share Repurchases | -820.82M | -369.58M | -388.88M | -80.64M | -73.07M | -6.94M | -6.31M | -57.45M | -3.83M | -151.80M |
| Debt Issued | — | — | 0 | 0 | 3.09B | 0 | 847.20M | 369.34M | 0 | 546.19M |
| Debt Repaid | 0 | -711.48M | -523.81M | -57.88M | -339.61M | 0 | -530.28M | 0 | 0 | — |
| Financing Cash Flow | -857.52M | -1.13B | -947.12M | -661.80M | 2.94B | -202.87M | -150.13M | -179.23M | 782.24M | -115.01M |
| Net Change in Cash | -243.42M | 250.08M | 443.63M | -148.59M | 216.72M | 210.72M | 25.58M | -36.05M | -174.20M | 138.30M |
| Free Cash Flow | 509.41M | 541.65M | 9.90M | 594.18M | 1.32B | 828.54M | 287.14M | 217.78M | 249.36M | 318.91M |
This table shows 10 annual periods of Revvity's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RVTY's reporting calendar. What is a cash flow statement?